1076 related articles for article (PubMed ID: 24215461)
1. In vitro susceptibility of dermatomycoses agents to six antifungal drugs and evaluation by fractional inhibitory concentration index of combined effects of amorolfine and itraconazole in dermatophytes.
Tamura T; Asahara M; Yamamoto M; Yamaura M; Matsumura M; Goto K; Rezaei-Matehkolaei A; Mirhendi H; Makimura M; Makimura K
Microbiol Immunol; 2014 Jan; 58(1):1-8. PubMed ID: 24215461
[TBL] [Abstract][Full Text] [Related]
2. In vitro activities of antifungal drugs against dermatophytes isolated in Tokat, Turkey.
Yenişehirli G; Tunçoğlu E; Yenişehirli A; Bulut Y
Int J Dermatol; 2013 Dec; 52(12):1557-60. PubMed ID: 24134487
[TBL] [Abstract][Full Text] [Related]
3. In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity.
Gupta AK; Kohli Y
Br J Dermatol; 2003 Aug; 149(2):296-305. PubMed ID: 12932235
[TBL] [Abstract][Full Text] [Related]
4. Determination of minimum inhibitory concentrations of itraconazole, terbinafine and ketoconazole against dermatophyte species by broth microdilution method.
Bhatia VK; Sharma PC
Indian J Med Microbiol; 2015; 33(4):533-7. PubMed ID: 26470960
[TBL] [Abstract][Full Text] [Related]
5. Antifungal susceptibilities of dermatophytic agents isolated from clinical specimens.
Cetinkaya Z; Kiraz N; Karaca S; Kulac M; Ciftci IH; Aktepe OC; Altindis M; Kiyildi N; Piyade M
Eur J Dermatol; 2005; 15(4):258-61. PubMed ID: 16048753
[TBL] [Abstract][Full Text] [Related]
6. Tacrolimus, not triamcinolone acetonide, interacts synergistically with itraconazole, terbinafine, bifonazole, and amorolfine against clinical dermatophyte isolates.
Zhang J; Tan J; Yang L; He Y
J Mycol Med; 2018 Dec; 28(4):612-616. PubMed ID: 30337054
[TBL] [Abstract][Full Text] [Related]
7. In vitro susceptibility testing of amorolfine in pathogenic fungi isolated from dermatomycosis patients in China.
Li RY; Wan Z; Wang AP; Shen YN; Lu CM; Li M; Xi LY; Liu WD; Zeng FQ
Mycoses; 2004 Oct; 47(9-10):402-6. PubMed ID: 15504124
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility of clinically important dermatophytes against statins and different statin-antifungal combinations.
Nyilasi I; Kocsubé S; Krizsán K; Galgóczy L; Papp T; Pesti M; Nagy K; Vágvölgyi C
Med Mycol; 2014 Feb; 52(2):140-8. PubMed ID: 24004389
[TBL] [Abstract][Full Text] [Related]
9. In vitro antifungal susceptibility patterns of dermatophyte strains causing tinea unguium.
Sarifakioglu E; Seçkin D; Demirbilek M; Can F
Clin Exp Dermatol; 2007 Nov; 32(6):675-9. PubMed ID: 17714532
[TBL] [Abstract][Full Text] [Related]
10. Use of the sensititre colorimetric microdilution panel for antifungal susceptibility testing of dermatophytes.
Pujol I; Capilla J; Fernández-Torres B; Ortoneda M; Guarro J
J Clin Microbiol; 2002 Jul; 40(7):2618-21. PubMed ID: 12089289
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis.
Bueno JG; Martinez C; Zapata B; Sanclemente G; Gallego M; Mesa AC
Clin Exp Dermatol; 2010 Aug; 35(6):658-63. PubMed ID: 19874354
[TBL] [Abstract][Full Text] [Related]
12. Comparison of disk diffusion method and broth microdilution method for antifungal susceptibility testing of dermatophytes.
Esteban A; Abarca ML; Cabañes FJ
Med Mycol; 2005 Feb; 43(1):61-6. PubMed ID: 15712608
[TBL] [Abstract][Full Text] [Related]
13. Antifungal activity of a soil isolate of Pseudomonas chlororaphis against medically important dermatophytes and identification of a phenazine-like compound as its bioactive metabolite.
Ranjbariyan A; Shams-Ghahfarokhi M; Razzaghi-Abyaneh M
J Mycol Med; 2014 Jun; 24(2):e57-64. PubMed ID: 24746720
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of Citrus bergamia (bergamot) oil against clinical isolates of dermatophytes.
Sanguinetti M; Posteraro B; Romano L; Battaglia F; Lopizzo T; De Carolis E; Fadda G
J Antimicrob Chemother; 2007 Feb; 59(2):305-8. PubMed ID: 17118937
[TBL] [Abstract][Full Text] [Related]
15. [In vitro antifungal activity of ravuconazole against isolates of dermatophytes and Candida species from patients with dermatomycoses].
Yamaguchi H; Ikeda F; Iyoda T; Suzuki M; Mikawa T
Med Mycol J; 2014; 55(4):J157-63. PubMed ID: 25742996
[TBL] [Abstract][Full Text] [Related]
16. How to: perform antifungal susceptibility testing of microconidia-forming dermatophytes following the new reference EUCAST method E.Def 11.0, exemplified by Trichophyton.
Arendrup MC; Kahlmeter G; Guinea J; Meletiadis J;
Clin Microbiol Infect; 2021 Jan; 27(1):55-60. PubMed ID: 32916260
[TBL] [Abstract][Full Text] [Related]
17. Antifungal drug susceptibility profile of clinically important dermatophytes and determination of point mutations in terbinafine-resistant isolates.
Salehi Z; Shams-Ghahfarokhi M; Razzaghi-Abyaneh M
Eur J Clin Microbiol Infect Dis; 2018 Oct; 37(10):1841-1846. PubMed ID: 29980898
[TBL] [Abstract][Full Text] [Related]
18. Synergistic activity of the combination of falcarindiol and itraconazole
Kan S; Tan J; Cai Q; An L; Gao Z; Yang H; Liu S; Na R; Yang L
Front Cell Infect Microbiol; 2023; 13():1128000. PubMed ID: 37207188
[TBL] [Abstract][Full Text] [Related]
19. Intra- and interlaboratory study of a method for testing the antifungal susceptibilities of dermatophytes.
Ghannoum MA; Chaturvedi V; Espinel-Ingroff A; Pfaller MA; Rinaldi MG; Lee-Yang W; Warnock DW
J Clin Microbiol; 2004 Jul; 42(7):2977-9. PubMed ID: 15243047
[TBL] [Abstract][Full Text] [Related]
20. Identification and antifungal susceptibility of fungi isolated from dermatomycoses.
Silva LB; de Oliveira DB; da Silva BV; de Souza RA; da Silva PR; Ferreira-Paim K; Andrade-Silva LE; Silva-Vergara ML; Andrade AA
J Eur Acad Dermatol Venereol; 2014 May; 28(5):633-40. PubMed ID: 23556501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]